» Articles » PMID: 25861290

Platelet-derived Growth Factors Induced Lymphangiogenesis: Evidence, Unanswered Questions and Upcoming Challenges

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2015 Apr 11
PMID 25861290
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Crosstalk between angiogenesis and lymphangiogenesis in embryonic development continues during postnatal life and has specific mechanisms involving factors that initiate activation of the intracellular cascade for their specific receptors. Platelet-derived growth factors (PDGFs) and their corresponding receptors (PDGFRs) are known as important regulators of blood vessel development in both normal and pathologic angiogenesis. Despite some recent papers which reported a potential role of the PDGF/PDGFR axis in lymphatic spread of tumor cells, a few papers have suggested the potential role of PDGFs in tumor lymphangiogenesis development. The present paper summarizes the potential lymphangiogenic role of the PDGF/PDGFR axis, underlying upcoming challenges in the field.

Citing Articles

Lymphangiogenesis Guidance Mechanisms and Therapeutic Implications in Pathological States of the Cornea.

Patnam M, Dommaraju S, Masood F, Herbst P, Chang J, Hu W Cells. 2023; 12(2).

PMID: 36672254 PMC: 9856498. DOI: 10.3390/cells12020319.


Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.

Wu R, Gandhi S, Tokumaru Y, Asaoka M, Oshi M, Yan L Breast Cancer Res Treat. 2022; 195(1):17-31.

PMID: 35793004 DOI: 10.1007/s10549-022-06661-w.


Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema.

Sung C, Gupta K, Wang J, Wong A Bioengineering (Basel). 2022; 9(4).

PMID: 35447722 PMC: 9025804. DOI: 10.3390/bioengineering9040162.


Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity.

Liang C, Yuan X, Shen Z, Wang Y, Ding L Mol Ther Oncolytics. 2022; 24:577-584.

PMID: 35252556 PMC: 8861424. DOI: 10.1016/j.omto.2022.01.001.


The lymphatic vasculature: An active and dynamic player in cancer progression.

Rezzola S, Sigmund E, Halin C, Ronca R Med Res Rev. 2021; 42(1):576-614.

PMID: 34486138 PMC: 9291933. DOI: 10.1002/med.21855.


References
1.
Rosenkranz S, Kazlauskas A . Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. Growth Factors. 1999; 16(3):201-16. DOI: 10.3109/08977199909002130. View

2.
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C . Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999; 126(14):3047-55. DOI: 10.1242/dev.126.14.3047. View

3.
Fambrough D, McClure K, Kazlauskas A, Lander E . Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell. 1999; 97(6):727-41. DOI: 10.1016/s0092-8674(00)80785-0. View

4.
Ferrara N . Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl). 1999; 77(7):527-43. DOI: 10.1007/s001099900019. View

5.
Wigle J, Oliver G . Prox1 function is required for the development of the murine lymphatic system. Cell. 1999; 98(6):769-78. DOI: 10.1016/s0092-8674(00)81511-1. View